Underweight TXN: Trim 40-50% into overbought strength, retain 50-60% core with condition-based re-entry
Underweight rating correctly encodes 'reduce exposure' while preserving franchise: asymmetry of -19-26% to fair value vs +6-12% to bull targets supports material trim but not full exit. Full Sell would forfeit franchise; Hold carries excessive concentration into binary catalyst with overbought technicals (RSI 71, above upper Bollinger). 40-50% trim captures favorable asymmetry—if Q3 disappoints, trimmed capital redeploys at better prices; if Q3 beats and guides up, residual 50-60% still participates toward $310-313.
| Position | Action |
|---|---|
| Current position > 50-60% core allocation | Trim 40-50% of existing TXN position into $290-295 strength zone |
| Post-trim residual core position | Maintain 50-60% core for franchise quality (300mm moat, 23-year dividend streak) |
| Hedging residual through Q3 print | Consider $280/$260 put spread on residual core to cap tail risk |
TXN is a fresh technical breakout with accelerating fundamentals, FCF inflection, and a structural 300mm cost moat that consensus underestimates, making 27.7x forward PE appear rich only if anchored to outdated 2026 estimates rather than the emerging 2027 margin structure.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $281.72 | bullish |
| close_50_sma | $270.73 | bullish |
| close_200_sma | $247.77 | bullish |
| rsi | 71.06 | neutral |
| boll_ub | $293.63 | bullish |
| boll_lb | $249.77 | neutral |
| macdh | +3.22 | bullish |
| atr | $8.03 | neutral |
Support: 281.72 · 270.73 · 258 · 247.77 | Resistance: 300 · 313 · 330
TXN is in a strong uptrend with price closing above the upper Bollinger Band at $294.90, though RSI at 71.06 suggests caution on chasing; prefer buying pullbacks to the $281-282 area over initiating new longs at current levels.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $260 without confirmation required
Then: Initiate or add to position at secondary zone
Q2 2026 revenue and EPS acceleration disprove the 'priced-in recovery' narrative
↩ rebuts: “Forward PE of 27.7x already prices in the recovery”
EV: +5.7% to +11.9% · concedes: The breakout is only 5 days old and could see a pullback to $281-282 (10 EMA) before resuming higher; DSO normalization from artificially depressed Q4 2025 levels bears monitoring; Q3 earnings 2-3 weeks out could introduce near-term volatility; Forward PE of 27.7x is above historical average, requiring execution on 2027 EPS targets; Industrial/auto revenue lag means labor market weakness could take 1-2 quarters to fully manifest in bookings
TXN is a richly-valued cyclical exiting a recovery quarter at the worst possible entry point, with asymmetric downside risk (~2:1) as the stock requires perfection across earnings recovery, margin expansion, and cycle acceleration while macro headwinds and an 80% receivables build threaten the bull thesis.
EV: -$19% to -26% (base case to $220-240) · concedes: Q2 2026 print is strong on a standalone basis; 300mm fabs are a legitimate long-term structural investment; Dividend of 2.07% provides some income support; TXN is a high-quality analog franchise; No retail euphoria means no cascade unwind risk
→ vs conservative: Full exit at current valuations abandons the franchise (42.6% operating margins, $2.19B FCF, self-funded dividend) and 300mm manufacturing moat for the privilege of avoiding 6-10% potential giveback - the fundamentals are not broken
→ vs conservative: The 80% receivables jump is not a smoking gun but a revenue inflection confirmation - when sales accelerate 13% sequentially from $4.82B to $5.46B, AR should balloon as expected
→ vs conservative: Forward PE of 27.7x and P/B of 15x are pricing in $10.64 EPS recovery, but Q2 alone implies annualized run rate north of $8.50, suggesting the stock is not overvalued on recovery fundamentals
→ vs neutral: HOLD into a binary catalyst with RSI at 71 and price above upper Bollinger Band is the most exposed position possible - not neutral but maximally vulnerable to volatility
→ vs neutral: Zero headlines and zero Reddit posts for a full week is data-scarcity neutrality, not confirmed balance neutrality - the name is flying under the radar before earnings with light positioning that amplifies any move
→ vs neutral: Trim-and-reload creates asymmetric opportunity on both sides by selling into thin, quiet, overbought tape and buying the dip when the herd panics at Q3 results
Market Cap
$269.3B
Trailing PE
44.9x
Forward PE
27.7x
PEG Ratio
1.05
Price/Book
14.95x
P/S (TTM)
~13.8x
Dividend Yield
2.07%
Beta
1.34
TTM Revenue
$19.45B
TTM Net Income
$6.02B
Shares Outstanding
~913M
TTM Gross Margin
58.3%
TTM Operating Margin
42.6%
TTM Net Margin
31.1%
TTM ROE
35.2%
TTM ROA
13.1%
TTM Free Cash Flow
$3.55B
TTM Dividends Paid
~$5.15B
Current Ratio
4.86
Cash & ST Investments
$7.00B
Total Debt
$14.05B
Net Debt
$10.39B
Debt/Equity
0.78
Revenue 2025
$17.68B
Revenue 2024
$15.64B
Revenue 2023
$17.52B
Revenue 2022
$20.03B
Gross Profit 2025
$10.08B
Operating Income 2025
$6.14B
Net Income 2025
$5.00B
Diluted EPS 2025
$5.45
Diluted EPS 2024
$5.20
Diluted EPS 2023
$7.07
Diluted EPS 2022
$9.41
Gross Margin 2025
57.0%
Operating Margin 2025
34.7%
Net Margin 2025
28.3%
Operating Cash Flow 2025
$7.15B
Capex 2025
$4.55B
Free Cash Flow 2025
$2.60B
Dividends Paid 2025
$5.00B
Buybacks 2025
$1.48B
FCF Coverage of Dividends 2025
0.52x
Q2 2026 Revenue
$5.46B
Q2 2026 Op Margin
42.6%
Q2 2026 Diluted EPS
$2.14
Q2 2026 FCF
$2.19B
Q2 2026 Capex
$514M
Interest Expense 2025
$543M
Book Value Per Share
$19.72
Strengths
Concerns
TXN presents a classic late-cycle recovery setup with revenue inflecting upward, operating leverage reappearing (42.6% margin in Q2 2026 vs. 34.7% trough), capex moderating, and dividend coverage restored. The forward PE of 27.7x is elevated but supported by normalized EPS of ~$10.64 (vs. TTM $6.57). However, with market cap already at $269B implying ~27x forward earnings, much of the recovery is priced in — the catalyst path from here is narrow and any disappointment carries meaningful downside in a richly-valued name.
Macro: Soft-landing under stress: U.S. recession odds at 8% (declining), labor data softening, Fed on hold with no 2026 cuts expected. Equity market showing narrow, mega-cap-led rally (Nasdaq at fresh highs; Dow and small caps lagging). Bond market seeing heavy TLT inflows suggesting institutional duration buying. A "bond king" (Gundlach) issued a sentiment warning that equity markets are stretched. Gold rising on weak jobs data. Polymarket odds show 96% probability of zero Fed rate cuts in 2026, with only 2% for a single cut.